Table 4.

Summary of adverse events

Adverse eventsa	8 mg (n=18)	16 mg (n=19)	32 mg (n=18)	64 mg (n=18)	128 mg (n=18)	Total
Dizzinessb	0 (0)	1 (1)	0 (0)	1 (1)	4 (4)	6 (6)
Headacheb	0 (0)	0 (0)	1 (1)	1 (1)	1 (1)	3 (3)
Light-headednessb	0 (0)	0 (0)	0 (0)	1 (1)	0 (0)	1 (1)
Paresthesiab	0 (0)	0 (0)	0 (0)	0 (0)	1 (1)	1 (1)
Bilirubin total increased	1 (1)	0 (0)	0 (0)	0 (0)	0 (0)	1 (1)
Blepharospasm	0 (0)	1 (1)	0 (0)	0 (0)	0 (0)	1 (1)

Notes:

^aData presented as number of subjects (number of events);

^bdrug-related adverse events.